z-logo
open-access-imgOpen Access
Demerits of Remdesivir: An Unseen Trouble
Author(s) -
Sundus Nasim,
Sohail Kumar,
Dua Azim,
Areej Haider Hashmi,
Muhammad Taha Nasim
Publication year - 2020
Publication title -
bangladesh journal of infectious diseases
Language(s) - English
Resource type - Journals
eISSN - 2411-670X
pISSN - 2411-4820
DOI - 10.3329/bjid.v7i00.50167
Subject(s) - economic shortage , covid-19 , medicine , intensive care medicine , alternative medicine , clinical trial , virology , infectious disease (medical specialty) , pathology , outbreak , government (linguistics) , linguistics , philosophy , disease
Remdesivir is an investigational antiviral agent available for COVID-19 therapy. Even though its efficacy has been proven through various clinical trials, the evidence is still scarce. The side effects of remdesivir are highlighted in this paper and should be kept in mind during its use. Moreover, the availability of this drug is limited, and we fear an impending shortage of the said medicine in the near future. Thus through this letter we hope to increase awareness regarding this potentially lifesaving medicine. Bangladesh Journal of Infectious Diseases, October 2020;7(suppl_2):S67-S68

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here